Cargando…
Inhibition of the thioredoxin system by PX-12 (1-methylpropyl 2-imidazolyl disulfide) impedes HIV-1 infection in TZM-bl cells
Human immunodeficiency virus (HIV-1) entry is initiated by the binding between the viral envelope glycoprotein gp120 and the host receptor CD4, and followed by reduction of structural disulfides of gp120 and CD4. The host thioredoxin-1 (Trx1) efficiently reduces disulfides of gp120 and CD4 in vitro,...
Autores principales: | Lundberg, Mathias, Mattsson, Åse, Reiser, Kathrin, Holmgren, Arne, Curbo, Sophie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449384/ https://www.ncbi.nlm.nih.gov/pubmed/30948772 http://dx.doi.org/10.1038/s41598-019-42068-2 |
Ejemplares similares
-
The Cellular Thioredoxin-1/Thioredoxin Reductase-1 Driven Oxidoreduction Represents a Chemotherapeutic Target for HIV-1 Entry Inhibition
por: Reiser, Kathrin, et al.
Publicado: (2016) -
Methodological Aspects of ELISA Analysis of Thioredoxin 1 in Human Plasma and Cerebrospinal Fluid
por: Lundberg, Mathias, et al.
Publicado: (2014) -
The combination of low level laser therapy and efavirenz drastically reduces HIV infection in TZM-bl cells
por: Lugongolo, Masixole Yvonne, et al.
Publicado: (2021) -
Hämatoonkologische Highlights von den TZM Essentials
por: Schumacher, Beate
Publicado: (2021) -
Hepatocyte Hyperproliferation upon Liver-Specific Co-disruption of Thioredoxin-1, Thioredoxin Reductase-1, and Glutathione Reductase
por: Prigge, Justin R., et al.
Publicado: (2017)